Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors
Abstract The potential for adoptive cell immunotherapy as a treatment against cancers has been demonstrated by the remarkable response in some patients with hematological malignancies using autologous T cells endowed with chimeric antigen receptors (CARs) specific for CD19. Clinical efficacy of CAR-...
Main Authors: | Erhao Zhang, Jieyi Gu, Hanmei Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-01-01
|
Series: | Molecular Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12943-018-0759-3 |
Similar Items
-
New Chimeric Antigen Receptor Design for Solid Tumors
by: Yuedi Wang, et al.
Published: (2017-12-01) -
Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors
by: Paris Kosti, et al.
Published: (2018-05-01) -
Chimeric antigen receptors designed to overcome transforming growth factor‐β‐mediated repression in the adoptive T‐cell therapy of solid tumors
by: Jordan Hartley, et al.
Published: (2019-01-01) -
Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications
by: Hamid R. Mirzaei, et al.
Published: (2017-12-01) -
Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy
by: Stefan Stoiber, et al.
Published: (2019-05-01)